Cardlytics, Inc. CDLX
Computer Software: Programming Data Processing · IPO 2018 · data as of November 13, 2026
Cardlytics, Inc. (CDLX) is a technology company listed in the US with a market value of about $8M. In the twelve months to September 30, 2026 it had revenue of $176M and net income of -$37M, a net margin of -20.8%.
Its overall Stock Analiz score is 0.8 out of 5 (weak). The strongest part is future growth (2/5); the weakest is financial health (0/5).
Key numbers: 5-year revenue growth of 5% a year, a 5-year average ROIC of -53%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 14% above the current price.
About Cardlytics
Cardlytics is listed in the US and classified in computer software: programming data processing, IPO year 2018. Revenue went from $113M in 2016 to $233M in 2025, growth of about 8.4% a year. It was profitable in 0 of the last 10 years in our data. Its share count rose by 59% over three years (dilution for shareholders). It spends 17% of revenue on research and development.
Score: 0.8 / 5
Checks passed
- Price below intrinsic value (DCF, moderate assumptions)
- Profit margin improving
- Strong R&D investment or growth above 20%
- ROE above 15%
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- 3-year free cash flow growth above 10% a year
- 5-year EPS growth above 10% a year
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $176M | $233M | $278M | $309M | $299M | $267M | $187M | $210M | $151M | $130M | $113M |
| Net income | -$37M | -$103M | -$189M | -$135M | -$465M | -$129M | -$55M | -$17M | -$53M | -$20M | -$76M |
| Free cash flow | -$7M | $9M | -$10M | -$852000 | -$55M | -$42M | -$13M | $3M | -$25M | -$23M | -$34M |
| EPS (diluted) | — | $-1.95 | $-3.91 | $-3.69 | $-13.92 | $-3.99 | $-2.04 | $-0.72 | $-2.79 | $-7.86 | $-32.48 |
| Net margin | -20.8% | -44.4% | -68.0% | -43.6% | -155.8% | -48.1% | -29.6% | -8.2% | -35.2% | -15.1% | -67.1% |
| ROIC | — | -47.9% | -65.9% | -36.3% | -102.1% | -13.0% | -15.7% | -12.1% | -41.4% | — | — |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
Frequently asked questions
Is Cardlytics stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 14% above the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Cardlytics pay a dividend?
Not currently.
Is Cardlytics a good stock to buy?
We do not give buy or sell advice. Cardlytics scores 0.8 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.